+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Burden of Hemoglobinopathies (Thalassemia, Sickle Cell Disorders and G6PD Deficiency) in Iran, 1990-2010: findings from the Global Burden of Disease Study 2010



Burden of Hemoglobinopathies (Thalassemia, Sickle Cell Disorders and G6PD Deficiency) in Iran, 1990-2010: findings from the Global Burden of Disease Study 2010



Archives of Iranian Medicine 18(8): 502-507



Hemoglobinopathies are known as the most common genetic disorders in Iran. The paper aims to provide global estimates of deaths and disability adjusted life years (DALYs) due to hemoglobinopathies in Iran by sex and age during 1990 to 2010 and describe the challenges due to limitations of the Global Burden of Disease Study 2010 (GBD 2010). GBD 2010 estimates of the numbers of deaths and years of life lost (YLLs) due to premature mortality were calculated using the Cause of Death Ensemble model (CODEm). Years of life lost due to disability (YLDs) were computed by multiplication of prevalence, the disability weight for occurrence of sequelae, and the duration of symptoms. Prevalence was estimated through a systematic search of published and available unpublished data sources, with a Bayesian meta-regression model developed for GBD 2010. Disability weights were produced using collected data from population-based surveys. Uncertainty from all inputs was incorporated into the computations of DALYs using simulation methods. We aim to prepare and criticize the results of GBD 2010 and provide some recommendations for reaching better conclusions about the burden of hemoglobinopathies in Iran. Between 1990 and 2010, the overall deaths attributed to hemoglobinopathies decreased from 0.51% to 0.36% of total deaths, with the corresponding burden declining from 1% to 0.82% of total DALYs. There was a reduction in deaths and DALYs rates for all ages and the rates attributed to all ages followed the same pattern in Iranian men and women. The highest DALYs for hemoglobinopathies, thalassemia, sickle cell disorder, and glucose-6-phosphate dehydrogenase deficiency (G6PD-D) were found in those aged less than 5 years. The collective burden of all of these hemoglobin disorder was lower in 2010 than in 1990. Although the screening programs in Iran have been very successful in reducing the number of thalassemia patients between 1990 to 2010, in order to provide a better estimation of the burden of hemoglobin disorders, it is necessary to perform a national and sub-national study of hemoglobinopathies using multiple national and sub-national surveys.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 057331468

Download citation: RISBibTeXText

PMID: 26265518


Related references

A Burden Assessment of Occupational Exposures in Iran, 1990-2010: Findings from the Global Burden of Disease Study 2010. International Journal of Preventive Medicine 9: 56, 2018

Burden of ischemic heart diseases in Iran, 1990-2010: Findings from the Global Burden of Disease study 2010. Journal of Research in Medical Sciences 20(11): 1077-1083, 2016

Burden of Oral Diseases in Iran, 1990-2010: Findings from the Global Burden of Disease Study 2010. Archives of Iranian Medicine 18(8): 486-492, 2016

Tobacco Smoking Status and the Contribution to Burden of Diseases in Iran, 1990-2010: findings from the Global Burden of Disease Study 2010. Archives of Iranian Medicine 18(8): 493-501, 2016

Burden of Cancers in Iran from 1990 to 2010: findings from the Global Burden of Disease study 2010. Archives of Iranian Medicine 18(10): 629-637, 2016

Burden of Hepatitis C in Iran Between 1990 and 2010: findings from the Global Burden of Disease Study 2010. Archives of Iranian Medicine 18(8): 508-514, 2016

Burden of Malaria in Iran, 1990-2010: Findings from the Global Burden of Disease Study 2010. Archives of Iranian Medicine 19(4): 241-247, 2017

Trends in health burden of ambient particulate matter pollution in Iran, 1990-2010: findings from the Global Burden of Disease study 2010. Environmental Science and Pollution Research International 22(23): 18645-18653, 2016

Trends in health burden of untreated water and insanitary environments in Iran, 1990-2010: Findings from the global burden of disease study 2010. Medical Journal of the Islamic Republic of Iran 30: 424, 2017

Burden of Sexually Transmitted Infections in Iran from 1990 to 2010: Results from the Global Burden of Disease study 2010. Archives of Iranian Medicine 19(11): 768-773, 2017

Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet. Global Health 1(5): E259-E281, 2015

Burden of Drug and Alcohol Use Disorders in Iran: findings from the Global Burden of Disease Study 2010. Archives of Iranian Medicine 18(8): 480-485, 2016

Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 383(9913): 245-254, 2014

National Burden of Eye Diseases in Iran, 1990-2010; Findings from the Global Burden of Diseases Study 2010. Middle East African Journal of Ophthalmology 23(1): 89-95, 2016

Burden Assessment of Thyroid cancer in Iran from 1990 to 2010: Lessons Obtained from Global Burden of Disease Report 2010. Asian Pacific Journal of Cancer Prevention 16(17): 7743-7748, 2016